KPRA Antibody (N-term)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- 产品详情
- 实验流程
Application ![]()
| WB, FC, E |
---|---|
Primary Accession | Q14558 |
Other Accession | Q63468, Q9D0M1, NP_002757.2 |
Reactivity | Human |
Predicted | Mouse, Rat |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 39394 Da |
Antigen Region | 30-59 aa |
Gene ID | 5635 |
---|---|
Other Names | Phosphoribosyl pyrophosphate synthase-associated protein 1, PRPP synthase-associated protein 1, 39 kDa phosphoribosypyrophosphate synthase-associated protein, PAP39, PRPSAP1 |
Target/Specificity | This KPRA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 30-59 amino acids from the N-terminal region of human KPRA. |
Dilution | WB~~1:1000 FC~~1:10~50 E~~Use at an assay dependent concentration. |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | KPRA Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | PRPSAP1 |
---|---|
Function | Seems to play a negative regulatory role in 5-phosphoribose 1-diphosphate synthesis. |
Tissue Location | Ubiquitous. |
Research Areas
For Research Use Only. Not For Use In Diagnostic Procedures.
Application Protocols
Provided below are standard protocols that you may find useful for product applications.
REFERENCES
Xin, X., et al. Genome Res. 19(7):1262-1269(2009)
Lamesch, P., et al. Genomics 89(3):307-315(2007)
Ewing, R.M., et al. Mol. Syst. Biol. 3, 89 (2007) :
Ishijima, S., et al. Biochim. Biophys. Acta 1342(1):28-36(1997)
Ishizuka, T., et al. Genomics 33(2):332-334(1996)

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.